Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands
- PMID: 33029766
- DOI: 10.1007/s10096-020-04061-w
Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands
Abstract
Purpose: In this study, we report the prevalence of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) amongst clinical specimens of patients suspected for sexually transmitted infections received at our laboratory and in addition report the prevalence of resistance-associated mutations (RAM) for ciprofloxacin in NG and azithromycin and moxifloxacin in MG.
Methods: All specimens received from December 2018 to May 2019 were tested for the four pathogens. In addition, the presence of RAM associated with resistance to ciprofloxacin in NG and to azithromycin and moxifloxacin in MG was determined by different real-time PCR assays on all NG- and MG-positive specimens.
Results: CT was detected most often (267/2613, 10.2%), followed by MG (106/2592, 4.1%), NG (41/2613, 1.6%) and TV (10/2592, 0.4%) amongst all specimens. The prevalence of ciprofloxacin RAM in NG was 21.2%, and the prevalence of RAM in MG was 40.6% for azithromycin and 8.1% for moxifloxacin. Nearly all specimens containing moxifloxacin-resistant MG also contained azithromycin-resistant MG.
Conclusion: CT is found most often in our population followed by MG and NG. By using molecular assays to detect RAM supplementary to pathogen identification of NG and MG, optimal therapy can be advised.
Keywords: Antimicrobial resistance; Fluoroquinolone; Macrolide.
References
-
- National multidisciplinar guideline for STIs (in Dutch). Accessed 22–01- 2020, https://www.soaaids.nl/files/2020-01/mdr-multidisciplinaire-richtlijn-so...
-
- de Jong AS, Rahamat-Langendoen JC, van Alphen P, Hilt N, van Herk C, Pont S, Melchers W, van de Bovenkamp J (2016) Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands. Int J STD AIDS 27:856–860 - DOI
-
- Jenniskens ML, Veerbeek JH, Deurloo KL, van Hannen EJ, Thijsen SF (2017) Routine testing of Mycoplasma genitalium and Trichomonas vaginalis. Infect Dis (Lond) 49:461–465 - DOI
-
- van der Veer C, van Rooijen MS, Himschoot M, de Vries HJ, Bruisten SM (2016) Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands. Sex Transm Infect 92:83–85 - DOI
-
- Staritsky L, Van Aar F, Visser M, Op de Coul E, Heijne J, Gotz H, Nielen M, Van Sighem A, Van Benthem B (2020) Surveillance report: sexually transmitted infections in the Netherlands in 2019. https://www.rivm.nl/bibliotheek/rapporten/2020-0052.pdf
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
